Encrantz Staffan 4
4 · Sight Sciences, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences Director Staffan Encrantz Receives RSU Award
What Happened
- Staffan Encrantz, a director of Sight Sciences, Inc. (SGHT) and reported 10% owner, was granted 28,261 restricted stock units (RSUs) on June 4, 2026. The Form 4 reports an acquisition at $0.00 per share (award/grant). The grant was valued at approximately $130,000 based on the closing price on the grant date. Each RSU represents a contingent right to one share of common stock and vests on the earlier of June 4, 2027 or the Company’s 2027 annual meeting, subject to continued service.
Key Details
- Transaction date: June 4, 2026; Form 4 filed June 5, 2026 (timely).
- Transaction type/code: Award/Grant (A); reported acquisition price $0.00.
- Shares granted: 28,261 RSUs (vesting contingent as noted above).
- Reported holdings after transaction: 1,391,922 shares of common stock plus 28,261 RSUs subject to vesting (per filing footnote).
- Notable footnotes: Grant made under the issuer’s Non‑Employee Director Compensation Program. Some reported shareholdings are held by a family trust (Reporting Person is a trustee) and by Allegro Investment Fund, L.P.; the reporting person disclaims beneficial ownership of certain fund/trust shares except to the extent of any pecuniary interest.
Context
- RSU grants are compensation awards, not open‑market purchases or sales; they don’t involve cash paid by the grantee and only convert to shares if and when they vest. Such awards are routine for non‑employee directors and reflect compensation rather than an immediate trading signal. As a reported 10% owner and director, Encrantz’s filing also discloses related holdings held in trust and an investment fund (with disclaimers of beneficial ownership).
Insider Transaction Report
Form 4
Encrantz Staffan
Director10% Owner
Transactions
- Award
Common Stock
[F1][F2]2026-06-04+28,261→ 1,420,183 total
Holdings
- 632,456(indirect: See footnote)
Common Stock
[F3] - 5,086,920(indirect: See footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
- [F2]Includes (i)1,391,922 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein.
- [F3]These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust for purposes of Rule 13d-3 under the Securities Exchange Act of 1934 (the "Exchange Act"). The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 under the Exchange Act or for any other purpose), except to the extent of his pecuniary interest therein, if any.
- [F4]These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the Chairman and CEO and sole director of Allegro Investment Inc., which is the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund for purposes of Rule 13d-3 under the Exchange Act. However, the Reporting Person does not have any pecuniary interest in the shares held by Allegro Investment Fund and disclaims beneficial ownership with respect to all such shares. Accordingly, these shares are being reported in this report voluntarily by the Reporting Person for informational purposes only and shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares for purposes of Section 16 under the Exchange Act or for any other purpose.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz|2026-06-05